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Life Sciences Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life 
science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list 
items might not apply to an individual manuscript, but all fields must be completed for clarity. 
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research 
policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist. 
`    Experimental design
1.   Sample size
Describe how sample size was determined. Line 563
2.   Data exclusions
Describe any data exclusions. n/a
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
all replicates reported
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Lines 446-447
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Lines  446-447
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Fiji (image processing), MATLAB (simulations, fits), FEMM (simulations)
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
n/a
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
n/a
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. n/a
b.  Describe the method of cell line authentication used. n/a
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
n/a
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
n/a
`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
Lines 449, 455, 462
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
n/a
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MRI Studies Reporting Summary
 Form fields will expand as needed. Please do not leave fields blank.
`    Experimental design
1.   Describe the experimental design. Structural imaging in the presence of contrast agent
2.   Specify the number of blocks, trials or experimental 
units per session and/or subject, and specify the 
length of each trial or block (if trials are blocked) 
and interval between trials.
n/a
3.   Describe how behavioral performance was 
measured.
n/a
`    Acquisition
4.   Imaging
a. Specify the type(s) of imaging. Structural imaging in the presence of contrast agent
b. Specify the field strength (in Tesla). 7 Tesla
c. Provide the essential sequence imaging parameters. lines 384-394, 466-478 
d. For diffusion MRI, provide full details of imaging 
parameters.
n/a
5.   State area of acquisition. Whole brain scan for brain imaging experiments, and full body imaging for 
mouse multiplexing and liver imaging experiments.
`    Preprocessing
6.   Describe the software used for preprocessing. Lines 495-412, 494-510
7.   Normalization
a. If data were normalized/standardized, describe the 
approach(es).
Not normalized/standardized.
b. Describe the template used for normalization/
transformation.
n/a
8.   Describe your procedure for artifact and structured 
noise removal.
None applied.
9.   Define your software and/or method and criteria 
for volume censoring, and state the extent of such 
censoring.
None applied
`    Statistical modeling & inference
10. Define your model type and settings. Statistical modeling was not applied.
11. Specify the precise effect tested. n/a
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12. Analysis
a. Specify whether analysis is whole brain or ROI-based. n/a
b. If ROI-based, describe how anatomical locations were 
determined.
n/a
13. State the statistic type for inference. 
(See Eklund et al. 2016.)
n/a
14. Describe the type of correction and how it is 
obtained for multiple comparisons.
n/a
15. Connectivity
a. For functional and/or effective connectivity, report the 
measures of dependence used and the model details.
n/a
b. For graph analysis, report the dependent variable and 
functional connectivity measure.
n/a
16. For multivariate modeling and predictive analysis, 
specify independent variables, features extraction 
and dimension reduction, model, training and 
evaluation metrics.
n/a
